This survey asks you to briefly reflect on the benefits of the A2S2 newsletters. Your feedback will help us improve future market intelligence projects.
A2S2 is a project financed by UNITAID to help support the production of artemisinin to ensure adequate supplies of ACTs (Artemisinin Based Combination Therapies) to meet forecasted malaria treatment requirements.